- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01330849
Toolkit for School Behavior Modification in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized Controlled Trial of a Behavior Modification Toolkit in Primary School Children With ADHD Behaviors
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is a debilitating and common disorder of childhood marked by pervasive and persistent patterns of inattention, overactivity and impulsiveness. It is associated with impairment in a range of domains at both home and school and leads to long term educational and vocational underachievement, delinquency and conduct disorder and social and marital problems. Current treatment approaches involve both pharmacological and non-pharmacological options. Non-pharmacological options tend to focus on home-based approaches such as parent training. These can be effective especially in limiting impairment and reducing symptoms of comorbid problems such as oppositional defiant disorder (ODD) and other psychiatric comorbidities. This can really improve the quality of life of children with ADHD. However, a major problem with these home-based approaches is that their effects are unlikely to generalise to the school setting. This means that to effectively treat ADHD and to deal with impairment at both home and at school one needs to supplement home based approaches with effective school based strategies.
Classroom-based approaches that have been tried with ADHD can be divided into two types (Pelham & Fabiano, 2008). First, there are classroom based management strategies where teachers manipulate the consequences of behaviour to reduce (i.e., negatively reinforce) inappropriate behaviours (aggression, loss of concentration, disruptiveness) and increase (reinforce) appropriate behaviours (compliance, concentration). The second type of intervention focuses on academic targets through manipulating the academic instruction and materials (i.e., reducing task length, peer tutoring). In the current proposal the investigators focus on the first category. Pelham & Fabiano (2008) recently concluded that "the evidence for BCM [behavioural classroom management] for ADHD was substantial".
However, while there is a considerable evidence base for the value of classroom management as a component of ADHD treatment in multi-modal psychosocial treatment packages in school-aged children, there is a lack of well designed randomized studies in a naturalistic school setting that can provide a definitive estimate of efficacy for such approaches.
At the University Hospital of Leuven a toolkit for school behaviour modification in children with ADHD has been developed and piloted. This is an instrument for teachers to systematically target specific behaviours in the classroom and the playground with the ultimate goal of improving school ADHD behaviours and reducing oppositionality. Teachers will identify the behaviours which are most challenging and apply a series of levels of intervention with increasing intensity of monitoring, feedback and training. The effect of a three month application of the toolkit will be evaluated compared to a waiting list control group. Outcome measures will include measures of ADHD behaviours, oppositional defiant behaviour, teacher attitudes towards ADHD, teacher-child relationship and child self-esteem.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3000
- Recruiting
- Universitair Ziekenhuis Leuven
-
Contact:
- Marina Danckaerts
- Phone Number: (+32)16343821
- Email: marina.danckaerts@uzleuven.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The teacher must rate the ADHD symptoms of the student above or equal to the 90,9th percentile on the inattention or hyperactivity/impulsivity subscale of the VvGK (a Dutch translation of the Disruptive Behaviour Disorders Rating Scale).
- There is a maximum of 2 children per classroom that may be included.
Exclusion Criteria:
- None (Medication use would not be a reason for exclusion from the sample if children still fulfill the inclusion criteria)(Children with mental retardation (IQ < 70) will automatically be excluded from the study, since the study runs in normal schools.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Toolkit intervention
|
For children allocated to the active intervention arm, teachers are trained to apply the ADHD Toolkit.
Teacher will use the behaviour modification tool for 3 months.
They are trained to select target behaviours causing impairment for the child and will apply a systematic approach of increased intensity of monitoring and feedback for the behaviour, including training of appropriate behaviour.
|
|
No Intervention: Waiting List Control Group
Children eligible for the study according to the inclusion criteria, but randomly allocated to the waiting list control group are promised to receive the intervention AFTER the study is finished.
|
Children in the control group will receive no specific intervention, but are promised that their teachers will apply the schoolkit for them after the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DBD Rating Scale: ADHD subscale, teacher rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), teacher rated.
|
Evaluation after using the ADHD Toolkit for a three month period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DBD Rating Scale: ADHD subscale, parent rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), parent rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
DBD Rating Scale, oppositional defiant disorder subscale, teacher rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), teacher rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
DBD Rating Scale, oppositional defiant disorder subscale, parent rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), parent rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
Target Behaviour Improvement Rating Scale, teacher rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
Target Behaviour Improvement Rating Scale = a 24-item questionnaire (unpublished) based on the 24 target school behaviours listed in the treatment manual of the ADHD Toolkit (URL: http://www.uzleuven.be/adhd-toolkit),
each item is scored on a four-point Likert scale, teacher rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
TRF, subscale internalizing problems
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
TRF = Teacher Report Form (Achenbach, 1991)
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
CBCL, subscale internalizing problems
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
CBCL= Child Behavior Checklist (Achenbach, 1991)
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
IRS, teacher rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
IRS= Impairment Rating Scale (Fabiano et al, 2006), teacher rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
IRS, parent rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
IRS= Impairment Rating Scale (Fabiano et al, 2006), parent rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
Perceived Competence Scale for Children
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
Perceived Competence Scale for Children (Harter, 1985)
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
Student-Teacher Relationship Scale
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
Student-Teacher Relationship Scale (Pianta, 1991)
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
Teachers Beliefs and Attitudes towards ADHD Scale, teacher rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
Teachers Beliefs and Attitudes towards ADHD Scale = A 20-item questionnaire (unpublished) looking at attributions of cause of ADHD, characteristics of children with ADHD and treatment options for ADHD.
This questionnaire is a modification of Charlotte Johnstons ADHD Beliefs and Attitudes Scale [Johnston, C.(2001).
ADHD Beliefs and Attitudes Scale.
Unpublished scale.].
Scoring on a seven-point Likert scale, teacher rated.
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
Feasibility, Acceptability and Usefulness Scale, teacher rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
Feasibility, Acceptability and Usefulness Scale = A 15-item questionnaire measuring the feasibility, acceptability and usefulness of the ADHD Toolkit intervention, scoring on a five-point Likert scale, teacher rated.
This questionnaire was developed specifically for this study (unpublished).
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
Feasibility, Acceptability and Usefulness Scale, student rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
Feasibility, Acceptability and Usefulness Scale = An 11-item questionnaire measuring the feasibility, acceptability and usefulness of the ADHD Toolkit intervention, scoring on a five-point Likert scale, student rated.
This questionnaire was developed specifically for this study (unpublished).
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
DBD Rating Scale, conduct disorder subscale, teacher rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), teacher rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
|
DBD Rating Scale, conduct disorder subscale, parent rated
Time Frame: Evaluation after using the ADHD Toolkit for a three month period
|
DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), parent rated
|
Evaluation after using the ADHD Toolkit for a three month period
|
Collaborators and Investigators
Investigators
- Principal Investigator: Marina Danckaerts, PhD, Universitaire Ziekenhuizen KU Leuven
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S52891
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention-deficit/Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
Clinical Trials on ADHD Toolkit
-
Universiteit LeidenLeids Universiteits FondsRecruiting
-
Dana-Farber Cancer InstituteNational Institute on Aging (NIA)Recruiting
-
Sunnybrook Health Sciences CentreScarborough General Hospital; Michael Garron Hospital; York Central Hospital,... and other collaboratorsCompleted
-
Arab Resource CollectiveModern University for Business and ScienceActive, not recruitingMental Health | Self Care | Performance EnhancementLebanon
-
University of MichiganCompletedWomen With BRCA 1 or BRCA 2 Mutation | Non-tested Female Family MembersUnited States
-
The University of Hong KongRecruiting
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)Not yet recruitingOpioid Use Disorder
-
NYU Langone HealthPatient-Centered Outcomes Research InstituteRecruiting
-
University of the PunjabRecruitingGestational Diabetes Mellitus in Pregnancy | Hypertension ,PregnancyPakistan
-
Children's Hospital Medical Center, CincinnatiCompletedAttention Deficit Hyperactivity DisorderUnited States